In the context of PCa, our findings that many preclinical and clinical studies highlight the correlation between HO-1 expression and PCa progression and poor clinical outcomes (summarized in Table 1) are consistent with the role of this stress protein in the prevention and treatment of cancer. Here, HMOX1 is linked to posterior cortical atrophy.